# SymPhysis Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/symphysis-medical

- Industry: Medical Devices & Equipment
- Headquarters: Galway, Ireland
- Website: www.symphysismedical.com/
- Total disclosed funding: $3.7M
- Latest round: Seed (Dec 21, 2023)
- Investors on record: 7

## About

Based in Galway, Ireland, and founded in 2018 by CEO Tim Jones, and CSO Michelle Tierney, SymPhysis Medical Limited operates as a provider of a patient-centric solution that primarily treats malignant pleural effusions (MPE). As of April 2022, the company employs 3 employees excluding its founders. In November 2025, SymPhysis Medical?received?EUR 1.25 million of?grant?funding?from new investor Rhode Island Life Science Hub.

The company provides releaze, a catheter-based technology system used to treat malignant pleural effusions or fluid build-up in the lungs of the last-stage cancer patients.

The company plans to utilize the November 2025 funding to set up its initial U.S. location in Rhode Island, move forward with regulatory approval, and form collaborations within New England’s life sciences community.

## Funding rounds

- Seed, Dec 21, 2023, $1.6M — Boole Investment Syndicate, Furthr VC, Irrus Investments
- Seed, Apr 25, 2022, $2M — Enterprise Ireland, Invest Northern Ireland, Boole Investment Syndicate, InterTradeIreland, Halo Business Angel Network, Furthr VC, Irrus Investments

## Investors

- Enterprise Ireland (https://capitalatlas.ai/funds/enterprise-ireland) — Seed
- Invest Northern Ireland — Seed
- Boole Investment Syndicate — Seed
- InterTradeIreland — Seed
- Halo Business Angel Network — Seed
- Furthr VC (https://capitalatlas.ai/funds/furthr-vc) — Seed
- Irrus Investments — Seed